Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE BERGNIER-DEBLOCQ : revenue, balance sheet and financial ratios

PHARMACIE BERGNIER-DEBLOCQ is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CHARLEVILLE-MEZIERES (08000), this company of category PME shows in 2025 a net income positive of 104 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BERGNIER-DEBLOCQ (SIREN 788749927)
Indicator 2025 2024 2023 2022 2021 2020 2019 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 103 823 € 76 373 € 143 143 € 182 221 € 146 590 € 152 100 € 211 568 € 218 829 € 195 613 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE BERGNIER-DEBLOCQ generates positive net income of 104 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 196 k€ -> 104 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

103 823 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.432%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

89.347%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

17.0%

Solvency indicators evolution
PHARMACIE BERGNIER-DEBLOCQ

Sector positioning

Debt ratio
4.43 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent

In 2025, the debt ratio of PHARMACIE BERGNIER-DEBLOCQ (4.43) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
89.35% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent +14 pts over 3 years

In 2025, the financial autonomy of PHARMACIE BERGNIER-DEBLOCQ (89.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 162.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

162.376

Liquidity indicators evolution
PHARMACIE BERGNIER-DEBLOCQ

Sector positioning

Liquidity ratio
162.38 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average -5 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE BERGNIER-DEBLOCQ (162.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMACIE BERGNIER-DEBLOCQ in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE BERGNIER-DEBLOCQ is estimated at 1 649 240 € (range 1 119 182€ - 2 587 885€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1119k€ 1649k€ 2587k€
1 649 240 € Range: 1 119 182€ - 2 587 885€
NAF 5 année 2025

Valuation method used

Net Income Multiple
103 823 € × 15.9x = 1 649 241 €
Range: 1 119 183€ - 2 587 886€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BERGNIER-DEBLOCQ with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE BERGNIER-DEBLOCQ

What is the revenue of PHARMACIE BERGNIER-DEBLOCQ ?

The revenue of PHARMACIE BERGNIER-DEBLOCQ is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE BERGNIER-DEBLOCQ profitable?

Yes, PHARMACIE BERGNIER-DEBLOCQ generated a net profit of 104 k€ in 2025.

Where is the headquarters of PHARMACIE BERGNIER-DEBLOCQ ?

The headquarters of PHARMACIE BERGNIER-DEBLOCQ is located in CHARLEVILLE-MEZIERES (08000), in the department Ardennes.

Where to find the tax return of PHARMACIE BERGNIER-DEBLOCQ ?

The tax return of PHARMACIE BERGNIER-DEBLOCQ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BERGNIER-DEBLOCQ operate?

PHARMACIE BERGNIER-DEBLOCQ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.